Predictive value of glycated albumin (GA%) versus glycosylated hemoglobin (HbA1c%) in follow up of glucose homeostasis in hemodialysis-maintained type -2 diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201910650895114

Enrollment

Registered

2019-10-21

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

abdominal ultrasound

haemodialsis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type-2 diabetic patients maintained on regular hemodialysis recently (less than one-year duration)

Exclusion criteria

Exclusion criteria: Type-1 DM; Conditions that affect blood homeostasis such as acute and chronic blood loss, recent blood transfusion, hemolytic anemia, splenomegaly, haemoglobinopathies, Liver cirrhosis, HIV positivity patients and Alcohol abuse subjects

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of HbA1c is higher than GA.	—

Secondary

Measure	Time frame
HOMA-IR is superior for both as regard sensitivity (100%) and diagnostic accuracy (85%) in such issue.	—

Countries

Egypt

Contacts

Public ContactElham Ahmed

Assisstant Profeesor

elhamo2011@gmail.com+20862156056

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026